Nanoceria and Its Biomedical Relevance

Abstract

Nanoceria is a nanosized particle preparation of cerium oxide. It shows mixture of cerium in the 3+ and 4+ states on the nanoparticle surface, giving it interesting redox properties. Nanoceria shows effective biological antioxidant properties, which makes it a great candidate for biomedical applications. Many studies have shown promising results on therapeutic potential of nanoceria in diseases like cancer, diabetes, atherosclerosis, and neurodegenerative diseases. Meanwhile, other studies explored biodistribution and toxicity of nanoceria. This review article describes nanoceria, its relevant biomedical applications, and adverse effects, based on previously reported studies.

Keywords

cerium oxide nanoparticles - antioxidant - reactive oxygen species - inflammatory diseases

• References

• 1 Dhall A, Self W. Cerium oxide nanoparticles: a brief review of their synthesis methods and biomedical applications. Antioxidants 2018; 7 (08) E97
• 2 Rajeshkumar S, Naik P. Synthesis and biomedical applications of Cerium oxide nanoparticles-A Review. Biotechnol Rep (Amst) 2017; 17: 1-5
• 3 Xu C, Qu X. Cerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological applications. NPG Asia Materials 2014; 6 (03) e90
• 4 Caputo F, Mameli M, Sienkiewicz A. et al. A novel synthetic approach of cerium oxide nanoparticles with improved biomedical activity. Sci Rep. 2017 7. (1). Doi: 10.1038/s41598-017-04098-6
• 5 Yokel RA, Hussain S, Garantziotis S, Demokritou P, Castranova V, Cassee FR. The Yin: An adverse health perspective of nanoceria: uptake, distribution, accumulation, and mechanisms of its toxicity. Environ Sci Nano 2014; 1 (05) 406-428
• 6 Naz S, Beach J, Heckert B. et al. Cerium oxide nanoparticles: a ‘radical’ approach to neurodegenerative disease treatment. Nanomedicine (Lond) 2017; 12 (05) 545-553
• 7 Hegazy MAE, Maklad HM, Elmonsif DAA, Elnozhy FY, Alqubiea MA, Alenezi FA. The possible role of cerium oxide (CeO₂) nanoparticles in prevention of neurobehavioral and neurochemical changes in 6-hydroxydopamineinduced parkinsonian disease. Alexandria Journal of Medicine 2017; 53 (04) 351-360
• 8 Pourkhalili N, Hosseini A, Nili-Ahmadabadi A. et al. Biochemical and cellular evidence of the benefit of a combination of cerium oxide nanoparticles and selenium to diabetic rats. World J Diabetes 2011; 2 (11) 204-210
• 9 Khurana A, Tekula S, Godugu C. Nanoceria suppresses multiple low doses of streptozotocin-induced Type 1 diabetes by inhibition of Nrf2/NF-κB pathway and reduction of apoptosis. Nanomedicine (Lond) 2018; 13 (15) 1905-1922
• 10 Chen J, Patil S, Seal S, McGinnis JF. Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides. Nat Nanotechnol 2006; 1 (02) 142-150
• 11 Wang K, Mitra RN, Zheng M, Han Z. Nanoceria-loaded injectable hydrogels for potential age-related macular degeneration treatment. J Biomed Mater Res A 2018; 106 (11) 2795-2804
• 12 Kim J, Kim HY, Song SY. et al. Synergistic oxygen generation and reactive oxygen species scavenging by manganese ferrite/ceria co-decorated nanoparticles for rheumatoid arthritis treatment. ACS Nano 2019; 13 (03) 3206-3217
• 13 Xue Y, St Hilaire C, Hortells L, Phillippi JA, Sant V, Sant S. Shape-specific nanoceria mitigate oxidative stress-induced calcification in primary human valvular interstitial cell culture. Cell Mol Bioeng 2017; 10 (05) 483-500
• 14 Kumari P, Saifi MA, Khurana A, Godugu C. Cardioprotective effects of nanoceria in a murine model of cardiac remodeling. J Trace Elem Med Biol 2018; 50: 198-208
• 15 Manne N, Arvapalli R, Graffeo VA. et al. Prophylactic treatment with cerium oxide nanoparticles attenuate hepatic ischemia reperfusion injury in sprague dawley rats. Cell Physiol Biochem 2017; 42 (05) 1837-1846
• 16 Saifi MA, Sangomla S, Khurana A, Godugu C. Protective effect of nanoceria on cisplatin-induced nephrotoxicity by amelioration of oxidative stress and pro-inflammatory mechanisms. Biol Trace Elem Res 2019; 189 (01) 145-156
• 17 Hirst SM, Karakoti A, Singh S. et al. Bio-distribution and in vivo antioxidant effects of cerium oxide nanoparticles in mice. Environ Toxicol 2013; 28 (02) 107-118
• 18 Niu J, Wang K, Kolattukudy PE. Cerium oxide nanoparticles inhibit oxidative stress and nuclear factor-κB activation in H9c2 cardiomyocytes exposed to cigarette smoke extract. J Pharmacol Exp Ther 2011; 338 (01) 53-61
• 19 Serebrovska Z, Swanson RJ, Portnichenko V. et al. Anti-inflammatory and antioxidant effect of cerium dioxide nanoparticles immobilized on the surface of silica nanoparticles in rat experimental pneumonia. Biomed Pharmacother 2017; 92: 69-77
• 20 Patel P, Kansara K, Singh R. et al. Cellular internalization and antioxidant activity of cerium oxide nanoparticles in human monocytic leukemia cells. Intl J Nanomed 2018; 13 (T-NANO 2014 Abstracts): 39-41
• 21 Zhou X, Wang B, Chen Y, Mao Z, Gao C. Uptake of cerium oxide nanoparticles and their influences on functions of A549 cells. J Nanosci Nanotechnol 2013; 13 (01) 204-215
• 22 Xu C, Lin Y, Wang J. et al. Nanoceria-triggered synergetic drug release based on CeO(2) -capped mesoporous silica host-guest interactions and switchable enzymatic activity and cellular effects of CeO(2). Adv Healthc Mater 2013; 2 (12) 1591-1599
• 23 Sack M, Alili L, Karaman E. et al. Combination of conventional chemotherapeutics with redox-active cerium oxide nanoparticles—a novel aspect in cancer therapy. Mol Cancer Ther 2014; 13 (07) 1740-1749
• 24 Sack-Zschauer M, Bader S, Brenneisen P. Cerium oxide nanoparticles as novel tool in glioma treatment: an. Vitro study. J Nanomed Nanotechnol 2017; 8 (06) 474
• 25 Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 2004; 56 (02) 185-229
• 26 Song HP, Jang JY, Bae SH, Choi SB, Yu BJ, Kim MI. Convenient colorimetric detection of thrombin via aptamer-mediated inhibition and restoration of the oxidase activity of nanoceria. J Nanosci Nanotechnol 2018; 18 (09) 6570-6574
• 27 Ni P, Xie J, Chen C. et al. Spectrophotometric determination of the activity of alkaline phosphatase and detection of its inhibitors by exploiting the pyrophosphate-accelerated oxidase-like activity of nanoceria. Mikrochim Acta 2019; 186 (05) 320
• 28 Liao H, Liu Y, Chen M, Wang M, Yuan H, Hu L. A colorimetric heparin assay based on the inhibition of the oxidase mimicking activity of cerium oxide nanoparticles. Mikrochim Acta 2019; 186 (05) 2741
• 29 Collin B, Oostveen E, Tsyusko OV, Unrine JM. Influence of natural organic matter and surface charge on the toxicity and bioaccumulation of functionalized ceria nanoparticles in Caenorhabditis elegans. Environ Sci Technol 2014; 48 (02) 1280-1289
• 30 Könen-Adıgüzel S, Ergene S. In vitro evaluation of the genotoxicity of CeO₂ nanoparticles in human peripheral blood lymphocytes using cytokinesis-block micronucleus test, comet assay, and gamma H2AX. Toxicol Ind Health 2018; 34 (05) 293-300
• 31 Eskandari N, Nejadi BabadaeiMM, Nikpur S. et al. Biophysical, docking, and cellular studies on the effects of cerium oxide nanoparticles on blood components: in vitro. Int J Nanomedicine 2018; 13: 4575-4589
• 32 Hussain S, Al-Nsour F, Rice AB. et al. Cerium dioxide nanoparticles induce apoptosis and autophagy in human peripheral blood monocytes. ACS Nano 2012; 6 (07) 5820-5829
• 33 Yokel RA, Tseng MT, Dan M. et al. Biodistribution and biopersistence of ceria engineered nanomaterials: size dependence. Nanomedicine (Lond) 2013; 9 (03) 398-407
• 34 Nemmar A, Al-Salam S, Beegam S, Yuvaraju P, Ali BH. The acute pulmonary and thrombotic effects of cerium oxide nanoparticles after intratracheal instillation in mice. Int J Nanomedicine 2017; 12: 2913-2922
• 35 Tseng MT, Lu X, Duan X. et al. Alteration of hepatic structure and oxidative stress induced by intravenous nanoceria. Toxicol Appl Pharmacol 2012; 260 (02) 173-182